Ketamine in the Treatment of Major Depressive Disorder

被引：3
|
作者：
Luu, Brent [1 ]
Rice, Elizabeth [1 ]
Goldin, Philippe [1 ]
机构：
[1] Univ Calif Davis, Betty Irene Moore Sch Nursing, Sacramento, CA 95817 USA
来源：
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2020年 / 16卷 / 03期
关键词：
depression; ketamine; major depressive disorder (MDD); mechanism of ketamine; psychiatric conditions; treatment of MDD; GAMMA-AMINOBUTYRIC-ACID; COMPLICATIONS; PHARMACOLOGY; INFUSIONS; GLUTAMATE; CARE;
D O I：
10.1016/j.nurpra.2019.07.016
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Major depressive disorder (MDD) is a prevalent and highly debilitating psychiatric condition that affects many young adults worldwide. This brief review summarizes the current available data about the use of ketamine as a treatment for MDD. We describe pharmacological mechanisms, dose considerations, drug interactions, side effects, and the relevancy of ketamine in the treatment of MDD. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码：228 / 231
页数：4
相关论文
共 50 条
  • [1] KETAMINE AS A TREATMENT FOR ADOLESCENT MAJOR DEPRESSIVE DISORDER
    Dwyer, Jennifer B.
    Bloch, Michael H.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S176 - S176
  • [2] Ketamine as a Treatment for Adolescent Major Depressive Disorder
    Dwyer, Jennifer
    Sanacora, Gerard
    Bloch, Michael
    [J]. BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S405 - S405
  • [3] The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder
    Chadi G Abdallah
    Andrea Jackowski
    Ramiro Salas
    Swapnil Gupta
    João R Sato
    Xiangling Mao
    Jeremy D Coplan
    Dikoma C Shungu
    Sanjay J Mathew
    [J]. Neuropsychopharmacology, 2017, 42 : 1739 - 1746
  • [4] The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder
    Abdallah, Chadi G.
    Jackowski, Andrea
    Salas, Ramiro
    Gupta, Swapnil
    Sato, Joao R.
    Mao, Xiangling
    Coplan, Jeremy D.
    Shungu, Dikoma C.
    Mathew, Sanjay J.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2017, 42 (08) : 1739 - 1746
  • [5] Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder
    Covvey, Jordan R.
    Crawford, Alexis Noble
    Lowe, Denise K.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (01) : 117 - 123
  • [6] Effect of Ketamine Treatment on Amygdala Responsivity in Major Depressive Disorder
    Loureiro, Joana
    Leaver, Amber
    Vasavada, Megha
    Kubicki, Antoni
    Joshi, Shantanu
    Njau, Stephanie
    Wade, Benjamin
    Espinoza, Randall
    Congdon, Eliza
    Narr, Katherine
    [J]. BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S291 - S291
  • [7] REPEATED KETAMINE TREATMENT FOR COMORBID MAJOR DEPRESSIVE DISORDER AND ALCOHOL USE DISORDER
    Yoon, G.
    Ralevski, E.
    Abdallah, C. G.
    Arias, A. J.
    Limoncelli, D.
    Newcomb, J.
    Jane, J. S.
    Sofuoglu, M.
    Krystal, J. H.
    Petrakis, I. L.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 : 97A - 97A
  • [8] Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
    Rong, Carola
    Park, Caroline
    Rosenblat, Joshua D.
    Subramaniapillai, Mehala
    Zuckerman, Hannah
    Fus, Dominika
    Lee, Yena L.
    Pan, Zihang
    Brietzke, Elisa
    Mansur, Rodrigo B.
    Cha, Danielle S.
    Lui, Leanna M. W.
    McIntyre, Roger S.
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (04):
  • [9] NALTREXONE PLUS KETAMINE FOR THE TREATMENT OF MAJOR DEPRESSIVE DISORDER AND ALCOHOL USE DISORDER
    Yoon, G.
    Ralevski, E.
    Arias, A. J.
    Limoncelli, D.
    Newcomb, J.
    Levy, L.
    Jane, J. S.
    Krystal, J. H.
    Petrakis, I. L.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 236A - 236A
  • [10] MicroRNAs, Social Defeat Stress, Major Depressive Disorder, and Ketamine Treatment
    不详
    [J]. NEUROSCIENTIST, 2023, 29 (01): : 8 - 8
12345